A test with high predictive value would accurately confirm disease presence if positive and exclude it if negative, circumventing risky and expensive laparoscopic surgery.
Last year saw remarkable advances, with seven products approved by the FDA, and currently 500 products are in the U.S. pipeline, with 10 to 20 new approvals expected in 2025.